Jnana Therapeutics

April 26, 2022
img: Featured

In October 2018, Neurocrine Biosciences entered into a research collaboration with Jnana Therapeutics to discover novel small molecule therapeutics for multiple targets associated with central nervous system (CNS) disorders. The collaboration leverages Jnana’s proprietary drug discovery platform across the solute carrier (SLC) family of transporters and Neurocrine Biosciences’ research and development expertise in CNS disorders to advance new medicines.